MedPath

Yoga in Treating Sleep Disturbance in Cancer Survivors

Phase 2
Completed
Conditions
Sleep Disorders
Cancer
Fatigue
Interventions
Procedure: Yoga Intervention (YOCAS)
Procedure: Standard Care Control Condition
Registration Number
NCT00397930
Lead Sponsor
Gary Morrow
Brief Summary

RATIONALE: Yoga may help improve sleep, fatigue, and quality of life in cancer survivors.

PURPOSE: This phase II trial is studying how well yoga works in treating sleep disturbance in cancer survivors.

Detailed Description

OBJECTIVES:

Primary

* Determine the efficacy of Hatha yoga in improving sleep quality in cancer survivors experiencing persistent sleep disturbance.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to gender and sleep disturbance rating reported on the eligibility assessment questionnaire (≤ 5 vs \> 5). Patients are randomized to 1 of 2 arms.

* Arm I: Patients receive standard care for 6 weeks. Patients may switch to the yoga intervention immediately after study completion.

* Arm II:Patients receive standard care for 2 weeks, followed by two 75-minute sessions of Hatha yoga per week for 4 weeks.

PROJECTED ACCRUAL: A total of 400 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
410
Inclusion Criteria
  • Diagnosis of any type of cancer
  • More than 1 primary cancer allowed
  • Has undergone and completed all forms of standard treatment (surgery, chemotherapy, radiation therapy) within the past 2 to 24 months
  • Patients can be on hormones such as Tamoxifen, or monoclonal antibodies like Herceptin
  • Persistent sleep disturbance, as indicated by a response of ≥ 3 when asked to rate their sleep on an 11-point scale (0 is equivalent to no sleep disturbance and 10 is the worst possible sleep disturbance)
  • Able to read English
  • 21 years of age or older
Exclusion Criteria
  • No prior or concurrent regular (≥ 1 day/week) participation in yoga classes or maintain regular personal practice of any form of yoga within the past 3 months
  • No diagnosis of sleep apnea
  • No concurrent cancer therapy with the exception of hormonal therapy (e.g., tamoxifen citrate) or monoclonal antibodies (e.g., trastuzumab [Herceptin®])
  • No metastatic cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Yoga Intervention (YOCAS)Yoga Intervention (YOCAS)Standardized Yoga for Cancer Survivors (YOCAS)
Standard Care Control ConditionStandard Care Control ConditionStandard follow-up care provided by their treating oncologists as appropriate for individual diagnoses.
Primary Outcome Measures
NameTimeMethod
Mean Post-Pre Change for the Pittsburgh Sleep Quality Inventory (PSQI)2-24 months after surgery, chemotherapy, and/or radiation therapy

Pittsburgh Sleep Quality Index: Measures sleep disturbance and usual sleep habits during the prior month only using seven clinically derived domains of sleep difficulties: sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction. Global PSQI is a summary of the seven domains. Each Domain is scored from 0 to 3, therefore PSQI has a range of 0 (better) to 21 (worse). Interpretation of the PSQI is that a score less than 5 is associated with good sleep quality and a score of 5 or greater is associated with poor sleep quality.

PSQI was calculated at both pre- and post-intervention for both arms. Pre-intervention PSQI was recorded during the week immediately before commencing the 4-week intervention. Post-intervention PSQI was recorded during the week immediately following the intervention. Mean post-pre change was calculated for both arms.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (11)

CCOP - Greenville

🇺🇸

Greenville, South Carolina, United States

CCOP - Kansas City

🇺🇸

Kansas City, Missouri, United States

CCOP - Grand Rapids

🇺🇸

Grand Rapids, Michigan, United States

CCOP - Central Illinois

🇺🇸

Decatur, Illinois, United States

CCOP - Kalamazoo

🇺🇸

Kalamazoo, Michigan, United States

CCOP - Columbus

🇺🇸

Columbus, Ohio, United States

CCOP - Wichita

🇺🇸

Wichita, Kansas, United States

CCOP - Columbia River Oncology Program

🇺🇸

Portland, Oregon, United States

CCOP - Hematology-Oncology Associates of Central New York

🇺🇸

East Syracuse, New York, United States

CCOP - Southeast Cancer Control Consortium

🇺🇸

Goldsboro, North Carolina, United States

CCOP - Northwest

🇺🇸

Tacoma, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath